Epigenetics & Chromatin operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
All manuscripts are reviewed by internationally recognized experts in the field, selected in part from our Editorial Board. Reviews are usually returned within 21 days, and the suitability of a manuscript for publication is assessed solely on criteria of scientific excellence. First and final decisions are made by the Editors-in-Chief.
Epigenetics & Chromatin considers the following types of article: Research, Methodology, and Review. For more specific information, please take a look at our Submission Guidelines.
Annual Journal Metrics
48 days to first decision for reviewed manuscripts only
33 days to first decision for all manuscripts
99 days from submission to acceptance
11 days from acceptance to publication
586 Altmetric mentions